Activation of peripheral CD8+T lymphocytes via CD28 plus CD2: Evidence for IL-2 gene transcription mediated by CD28 activation
- 1 January 1991
- journal article
- Published by Wiley in Tissue Antigens
- Vol. 37 (1) , 26-32
- https://doi.org/10.1111/j.1399-0039.1991.tb01840.x
Abstract
It is well established that peripheral CD8+ and CD4+ T cells display different requirements for in vitro activation by mitogenic mAb. Most CD4+ T cells can be activated by anti-CD3 or mitogenic combinations of anti-CD2. In contrast, CD8+ T cells display minimal responses to CD3 activation, and no proliferation is observed via CD2 activation. Purified peripheral blood CD8+ T cells, stringently depleted of APC, have been studied for their capacity to respond to mAb directed against CD3, CD2 and CD28, used alone or in combination. It is demonstrated that proliferation can be induced by co-stimulation of CD2 and CD28. This does not require autologous APC. CD8+ T cells can also be activated by the combination of anti-CD3 plus anti-CD28 in the presence of APC, but only minimal cell proliferation is obtained in the absence of APC. The response via CD2 plus CD28 is IL-2-dependent, as demonstrated by the ability of mAb against the IL-2 receptor to block proliferation, and is almost completely inhibited by cyclosporine A (CsA). These results suggest that the signal generated by stimulation of CD28 in combination with CD2 differs from that seen with CD28 activation combined with either PMA or CD3. Induction of IL-2 gene activation in CD8+, CD28+ peripheral T cells may therefore require additional "second signals", which are not necessary for activation of CD4+ cells. One such signal might be the interaction between CD28 and its natural ligand.Keywords
This publication has 41 references indexed in Scilit:
- Mitogenic activity of anti‐CD28 MoAb CLB‐CD28/1 on peripheral blood mononuclear cells and its cooperation with other anti‐T cells MoAb in the activation of purified T lymphocytesTissue Antigens, 1990
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- T lymphocytes and their CD4 subset are direct targets for the inhibitory effect of calcitriolCellular Immunology, 1989
- Human T cell activation: differential response to anti‐CD28 as compared to anti‐CD3 monoclonal antibodiesEuropean Journal of Immunology, 1989
- The T Cell Receptor/CD3 Complex: A Dynamic Protein EnsembleAnnual Review of Immunology, 1988
- Antibody-induced modulation of the CD3/T cell receptor complex causes T cell refractoriness by inhibiting the early metabolic steps involved in T cell activation.The Journal of Experimental Medicine, 1987
- A unique epitope on the CD2 molecule defined by the monoclonal antibody 9-1: epitope-specific modulation of the E-rosette receptor and effects on T-cell functionsHuman Immunology, 1986
- Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.The Journal of Experimental Medicine, 1986
- Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex.The Journal of Experimental Medicine, 1985
- A 45‐kDa human T‐cell membrane glycoprotein functions in the regulation of cell proliferative responsesEuropean Journal of Biochemistry, 1984